No paralogue variants have been mapped to residue 1668 for SCN5A.
SCN5A | RGAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIYSIFGMANFAYVKW-----EAG-----I | 1688 |
SCN1A | KGAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIYAIFGMSNFAYVKR-----EVG-----I | 1701 |
SCN2A | KGAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIYAIFGMSNFAYVKR-----EVG-----I | 1691 |
SCN3A | KGAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIYAIFGMSNFAYVKK-----EAG-----I | 1686 |
SCN4A | RGAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIYSIFGMSNFAYVKK-----ESG-----I | 1513 |
SCN7A | KGPKVFHNLMLPLMLSLPALLNIILLIFLV>M<FIYAVFGMYNFAYVKK-----EAG-----I | 1411 |
SCN8A | KGAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIFSIFGMSNFAYVKH-----EAG-----I | 1682 |
SCN9A | KGAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIYAIFGMSNFAYVKK-----EDG-----I | 1664 |
SCN10A | RAAKGIRTLLFALMMSLPALFNIGLLLFLV>M<FIYSIFGMSSFPHVRW-----EAG-----I | 1638 |
SCN11A | RAARGIRTLLFALMMSLPSLFNIGLLLFLI>M<FIYAILGMNWFSKVNP-----ESG-----I | 1528 |
CACNA1A | RQGYTIRILLWTFVQSFKALPYVCLLIAML>F<FIYAIIGMQVFGNIGIDVEDEDSDEDEFQI | 1733 |
CACNA1B | RQGYTIRILLWTFVQSFKALPYVCLLIAML>F<FIYAIIGMQVFGNIALDD---DTS-----I | 1633 |
CACNA1C | SRGEGIRTLLWTFIKSFQALPYVALLIVML>F<FIYAVIGMQVFGKIALND---TTE-----I | 1393 |
CACNA1D | SRGEGIRTLLWTFIKSFQALPYVALLIAML>F<FIYAVIGMQMFGKVAMRD---NNQ-----I | 1403 |
CACNA1E | RQGYTIRILLWTFVQSFKALPYVCLLIAML>F<FIYAIIGMQVFGNIKLDE---ESH-----I | 1640 |
CACNA1F | SKGEGIRTLLWTFIKSFQALPYVALLIAMI>F<FIYAVIGMQMFGKVALQD---GTQ-----I | 1360 |
CACNA1G | KMAVGMRALLDTVMQALPQVGNLGLLFMLL>F<FIFAALGVELFGDLECDET---HP--CEGL | 1779 |
CACNA1H | KMATGMRALLDTVVQALPQVGNLGLLFMLL>F<FIYAALGVELFGRLECSED---NP--CEGL | 1785 |
CACNA1I | KMATGMRALLDTVVQALPQVGNLGLLFMLL>F<FIYAALGVELFGKLVCNDE---NP--CEGM | 1655 |
CACNA1S | SRAEGVRTLLWTFIKSFQALPYVALLIVML>F<FIYAVIGMQMFGKIALVD---GTQ-----I | 1300 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.M1668T | c.5003T>C | Putative Benign | SIFT: Polyphen: |